Webinar "The New Frontier in PRROC: PD-L1 Testing in Immuno-Oncology in Ovarian Cancer: Insights from KEYNOTE-B96 Clinical Study"
The following topics will be discussed:
- Ovarian Cancer: epidemiology, histology classification and biomarkers
- PD-L1 Scoring Algorithm for Ovarian Cancer from the Phase III KEYNOTE-B96 (ENGOT-ov65) Landmark Trial
